CLINICAL_TRIALS
trial_result
· 2018-12-19
Clinical Trial Update: Acetazolamide for Treating NPH in Shunt-candidates Patients [Phase 2]
Summary
Phase 2 clinical trial evaluating acetazolamide for treating normal pressure hydrocephalus in shunt-candidate patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rabin Medical Center | Conditions: Normal Pressure Hydrocephalus | Phase 2 | Status: UNKNOWN